| Literature DB >> 30723572 |
Grigorios P Panotopoulos1, Ziyad S Haidar1,2,3,4.
Abstract
Predicting pharmacokinetics, based on the theory of dynamic systems, for an administered drug (whether intravenously, orally, intramuscularly, etc.), is an industrial and clinical challenge. Often, mathematical modeling of pharmacokinetics is preformed using only a measured concentration time profile of a drug administered in plasma and/or in blood. Yet, in dynamic systems, mathematical modeling (linear) uses both a mathematically described drug administration and a mathematically described body response to the administered drug. In the present work, we compare several mathematical models well known in the literature for simulating controlled drug release kinetics using available experimental data sets obtained in real systems with different drugs and nanosized carriers. We employed the χ 2 minimization method and concluded that the Korsmeyer-Peppas model (or power-law model) provides the best fit, in all cases (the minimum value of χ 2 per degree of freedom; χ min 2/d.o.f. = 1.4183, with 2 free parameters or m = 2). Hence, (i) better understanding of the exact mass transport mechanisms involved in drugs release and (ii) quantitative prediction of drugs release can be computed and simulated. We anticipate that this work will help devise optimal pharmacokinetic and dynamic release systems, with measured variable properties, at nanoscale, characterized to target specific diseases and conditions.Entities:
Year: 2019 PMID: 30723572 PMCID: PMC6339717 DOI: 10.1155/2019/9153876
Source DB: PubMed Journal: Scientifica (Cairo) ISSN: 2090-908X
First data set (DOX) (from [8]).
| Number of time point | Time (h) | Drug dissolution (%) | Error bars |
|---|---|---|---|
| 1 | 1 | 10 | 7 |
| 2 | 2 | 20 | 7 |
| 3 | 4 | 30 | 3 |
| 4 | 5 | 38 | 3 |
| 5 | 7.5 | 42 | 7 |
| 6 | 10 | 48 | 2 |
| 7 | 12 | 50 | 8 |
| 8 | 24 | 60 | 2 |
| 9 | 35 | 65 | 5 |
| 10 | 48 | 70 | 1 |
Second data set (MTX) (from [8]).
| Number of time point | Time (h) | Drug dissolution (%) | Error bars |
|---|---|---|---|
| 1 | 1 | 2 | 1 |
| 2 | 2 | 5 | 1 |
| 3 | 4 | 10 | 1 |
| 4 | 5 | 15 | 1 |
| 5 | 7.5 | 19 | 1 |
| 6 | 10 | 21 | 1 |
| 7 | 12 | 25 | 1 |
| 8 | 24 | 35 | 1 |
| 9 | 35 | 40 | 1 |
| 10 | 48 | 45 | 1 |
Third data set (PLGA NPs) (from [9]).
| Number of time point | Time (d) | Drug dissolution (%) | Error bars |
|---|---|---|---|
| 1 | 1 | 10 | 2.5 |
| 2 | 2 | 18 | 2.5 |
| 3 | 3 | 23 | 4 |
| 4 | 4 | 27 | 3 |
| 5 | 5 | 29 | 3 |
| 6 | 7 | 34 | 3 |
| 7 | 8 | 36 | 3 |
| 8 | 12 | 40 | 3 |
| 9 | 15 | 43 | 3 |
| 10 | 18 | 44 | 4 |
| 11 | 24 | 45 | 3 |
| 12 | 30 | 46 | 2.5 |
Fourth data set (CA-PLGA NPs) (from [9]).
| Number of time point | Time (d) | Drug dissolution (%) | Error bars |
|---|---|---|---|
| 1 | 1 | 20 | 2.5 |
| 2 | 2 | 27 | 2.5 |
| 3 | 3 | 32 | 3 |
| 4 | 4 | 38 | 2.5 |
| 5 | 5 | 43 | 5 |
| 6 | 7 | 49 | 3 |
| 7 | 8 | 53 | 5 |
| 8 | 12 | 55 | 3 |
| 9 | 15 | 57 | 3 |
| 10 | 18 | 58 | 2.5 |
| 11 | 24 | 58 | 3 |
| 12 | 30 | 59 | 3 |
Fifth data set (PD-PCL-NC) (from [10]).
| Number of time point | Time (h) | Drug dissolution (%) | Error bars |
|---|---|---|---|
| 1 | 0 | 0 | 1 |
| 2 | 0.5 | 45 | 1 |
| 3 | 1 | 65 | 1 |
| 4 | 2 | 80 | 1 |
| 5 | 3 | 90 | 1 |
| 6 | 4 | 95 | 1 |
| 7 | 5 | 97.5 | 1 |
| 8 | 6 | 100 | 2.5 |
Figure 1Schematic illustration of the nanoparticulate dual-drug delivery system.
Figure 2Drug dissolution versus time, for the first data set presented in Table 1. Shown are the data points, the Higuchi model (red color), and the power law model (black color) which fits the data better than the Higuchi model.
Values of parameters for the first data set (N=10).
| Model | First parameter | Second parameter |
|
|---|---|---|---|
| Higuchi ( |
| — | 13.1467 |
| Power-law ( |
|
| 1.4183 |
| Hopfenberg ( |
| — | 69.1869 |
| Zero order ( |
|
| 5.9920 |
| Hixson–Crowell ( |
|
| 7.0212 |
| First order ( |
|
| 7.4994 |